Skip to main content
. 2019 Mar 13;11(5):1524–1536. doi: 10.18632/aging.101850

Table 3. Correlations between hormonal parameters and the levels of polyunsaturated fatty acids in BPH patients with and without MetS.

Variables Patients with BPH and METS Patients with BPH and without METS
DHEA E2 SHBG LH TT TF IGF1 I DHEA E2 SHBG LH TT TF IGF1 I
C10:0 Capric acid P 0.055 0.132 -0.273 -0.014 -0.151 0.367* -0.263 0.036 -0.038 0.039 -0.125 -0.212* 0.010 -0.004 -0.024 -0.128
p 0.696 0.350 0.050 0.920 0.285 0.007 0.059 0.825 0.714 0.706 0.228 0.039 0.925 0.969 0.821 0.256
C12:0 Lauric acid P 0.178 -0.095 -0.230 0.030 -0.243 -0.153 -0.194 0.140 0.042 0.111 -0.221* -0.119 -0.095 -0.031 -0.030 0.111
p 0.207 0.501 0.101 0.833 0.083 0.279 0.168 0.383 0.689 0.288 0.032 0.255 0.360 0.767 0.775 0.329
C14:0 Myristic acid P 0.068 -0.046 -0.378* -0.003 -0.267 0.082 -0.213 0.062 0.125 0.147 -0.272* -0.096 0.004 0.088 0.063 0.191
p 0.630 0.746 0.006 0.986 0.056 0.562 0.129 0.701 0.229 0.155 0.008 0.356 0.973 0.396 0.541 0.090
C16:0 Palmitic acid P 0.183 -0.032 -0.329* -0.025 -0.308* 0.160 -0.137 0.049 0.166 0.058 -0.141 -0.091 0.125 0.150 0.153 0.060
p 0.193 0.820 0.017 0.859 0.026 0.256 0.332 0.761 0.108 0.579 0.174 0.380 0.227 0.147 0.138 0.598
C18:0 Stearic acid P 0.304* -0.062 -0.283* -0.123 -0.375* 0.004 -0.158 -0.023 0.086 -0.024 -0.100 -0.070 0.077 0.089 0.220* 0.024
p 0.028 0.660 0.042 0.385 0.006 0.975 0.263 0.885 0.409 0.819 0.337 0.500 0.457 0.389 0.032 0.832
C18:1n9 cis/trans Oleic acid P 0.196 0.015 -0.305* 0.048 -0.273 0.231 -0.149 0.059 0.170 0.096 -0.132 -0.136 0.076 0.115 0.180 0.045
p 0.165 0.915 0.028 0.733 0.050 0.100 0.293 0.714 0.099 0.355 0.202 0.189 0.464 0.267 0.082 0.694
C18:1 trans vaccinic acid P 0.382* -0.025 -0.276* -0.006 -0.256 0.161 -0.145 0.053 0.210* 0.084 -0.037 -0.068 0.098 0.164 0.266* 0.028
p 0.005 0.861 0.048 0.968 0.067 0.254 0.304 0.744 0.042 0.416 0.725 0.515 0.347 0.113 0.009 0.807
C18:2n6c Linolenic acid P 0.128 -0.015 -0.283* -0.150 -0.284* 0.080 -0.129 -0.051 0.072 -0.009 -0.080 -0.090 0.059 0.062 0.310* -0.022
p 0.365 0.915 0.042 0.290 0.041 0.573 0.363 0.751 0.487 0.931 0.443 0.385 0.573 0.548 0.002 0.848
C18:3n6 gamma linolenic acid P 0.138 -0.029 -0.283* 0.056 -0.225 0.117 -0.262 -0.020 -0.005 0.127 -0.213* 0.003 0.037 0.073 -0.004 0.053
p 0.328 0.839 0.042 0.693 0.109 0.411 0.060 0.900 0.965 0.220 0.038 0.978 0.720 0.484 0.967 0.643
C18:3n3 linolenic acid P 0.020 -0.002 -0.314* -0.131 -0.289* 0.117 -0.122 0.041 0.002 0.009 -0.130 -0.111 -0.176 -0.040 0.213* 0.009
p 0.890 0.987 0.024 0.356 0.038 0.409 0.390 0.798 0.982 0.929 0.208 0.283 0.088 0.700 0.038 0.933
C20:0 Arachidic acid P -0.109 0.183 -0.244 -0.013 -0.322* <0.001 -0.155 0.173 -0.069 -0.044 -0.122 0.025 -0.139 -0.098 -0.077 -0.131
p 0.467 0.218 0.099 0.932 0.027 0.998 0.298 0.306 0.569 0.717 0.310 0.834 0.249 0.418 0.524 0.311
C22:1 cis11- eicosenic acid P 0.316* 0.082 -0.243 -0.082 -0.285* 0.193 -0.189 0.058 0.210* -0.024 -0.129 0.016 -0.026 0.121 0.247* -0.042
p 0.023 0.564 0.083 0.564 0.040 0.171 0.181 0.719 0.041 0.816 0.213 0.881 0.805 0.242 0.016 0.710
C20:2 cis-11-eicosadienoic acid P 0.317* -0.138 -0.234 -0.049 -0.256 -0.012 -0.188 0.032 0.192 -0.032 -0.062 -0.084 0.082 0.162 0.217* 0.113
p 0.023 0.335 0.099 0.734 0.070 0.931 0.188 0.842 0.067 0.765 0.557 0.428 0.437 0.123 0.038 0.326
C20:3n6 eicosatrienoic acid P 0.294* 0.048 -0.307* -0.080 -0.366* 0.021 -0.155 0.044 0.117 -0.029 -0.126 -0.106 0.057 0.145 0.166 0.107
p 0.035 0.734 0.027 0.572 0.008 0.885 0.274 0.782 0.258 0.783 0.225 0.309 0.583 0.162 0.109 0.344
C20:4n6 Arachidonic acid P 0.305* 0.056 -0.284* -0.181 -0.307* 0.132 -0.132 0.018 0.034 0.036 -0.089 -0.027 0.081 0.005 0.205* -0.049
p 0.028 0.693 0.042 0.200 0.027 0.351 0.352 0.912 0.744 0.731 0.390 0.793 0.438 0.958 0.047 0.663
C20:5n3 EPA P -0.038 0.143 -0.089 -0.349* -0.172 0.061 -0.103 0.068 -0.025 0.008 -0.198 0.291* -0.113 -0.046 0.014 0.057
p 0.789 0.311 0.531 0.011 0.224 0.668 0.468 0.671 0.808 0.941 0.054 0.004 0.276 0.655 0.896 0.618
C22:5w3 (docosapentaenate) P 0.241 0.044 -0.082 -0.172 -0.169 0.179 -0.207 0.024 0.131 <0.001 -0.092 -0.052 0.078 0.120 0.139 -0.036
p 0.086 0.755 0.562 0.221 0.230 0.205 0.140 0.880 0.206 0.999 0.376 0.615 0.451 0.248 0.180 0.753
C22:6n3 DHA P 0.236 0.016 -0.081 -0.275* -0.152 0.096 -0.013 -0.061 -0.086 -0.028 -0.192 0.174 -0.150 -0.095 0.208* 0.076
p 0.092 0.910 0.567 0.048 0.282 0.498 0.926 0.705 0.407 0.786 0.062 0.091 0.146 0.359 0.043 0.500
LTX A4 5S, 6R, 15R P -0.048 0.115 -0.221 0.035 -0.148 -0.041 -0.097 0.422* -0.034 -0.077 -0.351* -0.136 -0.202 -0.062 -0.046 0.009
p 0.738 0.417 0.115 0.807 0.294 0.775 0.495 0.006 0.745 0.462 0.001 0.190 0.051 0.551 0.660 0.935
LTX A4 5S, 6R P -0.083 0.055 -0.259 0.065 -0.153 -0.083 -0.092 0.239 -0.007 -0.025 -0.348* -0.130 -0.184 -0.031 -0.048 0.045
p 0.559 0.701 0.064 0.647 0.279 0.560 0.515 0.132 0.945 0.808 0.001 0.213 0.076 0.767 0.648 0.691

(BPH, benign prostatic hyperplasia; METS, metabolic syndrome; p, statistical significance; P, correlation coefficient; TT, total testosterone; TF, free testosterone; SHBG, sex hormone binding globulin; E2, estradiol; DHEAs, dehydroepiandrosterone sulfate; LH, luteinizing hormone; IGI-1, insulin like grow factor-1; I, insulin; *, statistical significant parameter)